Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs
- 1 July 1968
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 18 (7), 706
- https://doi.org/10.1212/wnl.18.7.706
Abstract
Inhibition of of diphenylhydantoin metabolism by isonicotinic acid hydrazide [INH], para-amino salicylic acid [PAS], and cycloserine was studied in rats and in rat liver microsomal preparations. The studies in vivo suggested that inhibition followed a dose of 6 mg of INH per kg of body weight and that a gradually increasing degree of inhibition could be produced by increasing INH doses. The inhibition was manifested by an elevation of blood levels of diphenylhydantoin and prolongation of the duration of the elevated blood levels when compared with control animals receiving diphenylhydantoin alone. The studies in vitro revealed that parahydroxylation of diphenylhydantoin was inhibited by INH and PAS in a noncompetitive manner. INH was the most potent inhibitor (active in range of 10-5 M). Inhibition produced by combined addition of INH and PAS was greater than the sum of inhibitions obtained with the same concentrations of either drug alone.This publication has 6 references indexed in Scilit:
- Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapyNeurology, 1966
- Diphenylhydantoin Metabolism, Blood Levels, and ToxicityArchives of Neurology, 1964
- OUTBREAK OF UNEXPECTED REACTIONS AMONG EPILEPTICS TAKING ISONIAZIDPublished by Elsevier ,1962
- STUDIES ON 5,5'-DIPHENYLHYDANTOIN (DILANTIN) IN ANIMALS AND MAN1956
- THE ENZYMATIC METABOLISM OF HEXOBARBITAL (EVIPAL)1955
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934